Rivaroxaban reduces risk of venous thromboembolismTreatment with the oral factor Xa inhibitor rivaroxaban reduces the risk of recurrent venous thromboembolism—and it does so without an increase in bleeding, researchers said here. Renal denervation shows promise in refractory hypertensionCatheter ablation of sympathetic nerves produces significant blood pressure reductions Abdominal massage eases constipation in MS patients Success of small feasibility study could lead to full multicentre trial Omega-3s fail to fix atrial fibrillation Report confirms disproportionate toll of drug abuse Giant rats detect TB Notorious autism paper a fraud, journal declares Hospital funding models need update: OMA New Ontario Medical Association paper considers activity-based funding versus global hospital funding New agent offers hope for rare bleeding disorder Recombinant factor XIII product reduced the number of bleeding episodes and avoided risks linked to blood products Obesity: Healthcare providers contribute to discrimination 1st Canadian Summit on Weight Bias and Discrimination First Previous 379 380 381 382 383 Next Last
